Form 8-K - Current report:
SEC Accession No. 0001564590-22-018687
Filing Date
2022-05-09
Accepted
2022-05-09 06:30:35
Documents
15
Period of Report
2022-05-03
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K txmd-8k_20220503.htm   iXBRL 8-K 39547
2 EX-3.1 txmd-ex31_8.htm EX-3.1 42878
3 GRAPHIC gvaqbzovspaz000002.jpg GRAPHIC 6067
4 GRAPHIC gvaqbzovspaz000001.jpg GRAPHIC 5114
  Complete submission text file 0001564590-22-018687.txt   235875

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA txmd-20220503.xsd EX-101.SCH 5613
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20220503_lab.xml EX-101.LAB 20065
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20220503_pre.xml EX-101.PRE 11952
9 EXTRACTED XBRL INSTANCE DOCUMENT txmd-8k_20220503_htm.xml XML 3678
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 22903155
SIC: 2834 Pharmaceutical Preparations